Devatis Limited is a licensed pharmaceutical company in New Zealand. Being active since 2007 in New Zealand, the company was initially incorporated as DEVA Holdings NZ Ltd and amended its name as Devatis Limited as of March 20, 2017. Devatis Limited is 100% owned by DEVA Holding A.S. which is one of the leading pharmaceutical companies in Turkey. Through DEVA Holding A.S., Devatis Ltd. is a part of globally active EastPharma group companies. Having an enterprising and innovative attitude in the pharmaceutical market, DEVA Holding A.S. is active in several important territories all over the world. The essential aim is to make perfect quality medicines available for everyone. In this respect, DEVA is working devotedly at its EU-GMP and US FDA approved, state-of-art manufacturing facilities with approximately 2500 employees.

Established in 1958, DEVA Holding has approximately 600 products in in the Turkish pharmaceuticals market and with excellent manufacturing capabilities for nearly all kind of pharmaceutical forms, DEVA develops, produces, markets and sells its high-quality finished products, APIs and veterinary products worldwide. DEVA offers a wide range of products in various therapeutical areas including antibacterial, antineoplastic, musculoskeletal, cardiovascular, gastrointestinal, respiratory, central nervous system, dermatology and hormones.

Comprehensive Product Portfolio

DEVA Holding has approximately 600 products in 13 therapeutic areas including Hematology & oncology, ophthalmology and respiratory system products amongst others creating difference by launching new products into market every single year.

Manufacturing Capabilities

DEVA production facilities have been approved and certified by EU GMP and US FDA with an annual output capacity of 578 million units. Manufacturing capacity allows production of different pharmaceutical forms at large scales:

• Tablets

• Capsules

• Injectable Products (Ampoules, Vials)

• Eye Drops

• Sterile Pomads

• Gels & Ointments

• Suspensions

• Suppository

• Syrups and Solutions

• Metered-Dose Inhalers (MDI) and Dry-Powder Inhalers (DPI)

Established Quality Standards

The high quality of DEVA production facilities are endorsed by globally recognized certification bodies:

•  EU – GMP (German Health Authority - Baden Württemberg, Portuguese Health Authority - Infarmed)
•  FDA (U.S. Food and Drug Administration)
•  MedSafe (New Zealand Medicines and Medical Devices Safety Authority)
•  ISO 9001 Quality Management System
•  ISO 27001 Information Security Management System
•  ISO 14001 Environmental Management System
•  BS OHSAS 18001 Occupational Health and Safety Management

Manufacturing Facilities

DEVA has three manufacturing facilities which are endorsed by internationally recognized certifications proving the high quality standards of DEVA.